Literature DB >> 1910069

Risk factors for Crimean-Congo hemorrhagic fever in rural northern Senegal.

L E Chapman1, M L Wilson, D B Hall, B LeGuenno, E A Dykstra, K Ba, S P Fisher-Hoch.   

Abstract

The extent of infection among 722 residents of an enzootic focus of Crimean-Congo hemorrhagic fever (CCHF) virus in rural northern Senegal and putative modes of transmission were studied by a cross-sectional seroprevalence survey done from February through May 1989. Anti-CCHF virus IgG was found in 13.1% of 283 persons who completed a standard questionnaire and provided blood samples. Seropositivity rates were similar between sexes and increased significantly with age among nomadic persons. Behavior patterns providing exposure to multifactorial risk factors were gender-based. Male risk factors, primarily associated with herding activities, included sleeping outside during seasonal migrations (also a risk factor for nomadic women), bite by a tick (adult male Hyalomma truncatum), tick bite during the cool dry season, and contact with sick animals. Human infection of CCHF occurred more frequently or with less mortality in the region studied than has been found elsewhere in Africa; however, the rate of seroconversion-associated illness is undetermined. Hyalomma ticks appear to be the primary transmission mode.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910069     DOI: 10.1093/infdis/164.4.686

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Crimean-Congo hemorrhagic fever in Kosovo.

Authors:  Christian Drosten; Dirk Minnak; Petra Emmerich; Herbert Schmitz; Thomas Reinicke
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 2.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

3.  An unusual intracerebral hemorrhage.

Authors:  Roya Alavi-Naini; Ali Moghtaderi; Malyhe Metanat
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-05       Impact factor: 2.471

4.  Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Koji Sakai; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Imported Crimean-Congo hemorrhagic Fever.

Authors:  Stéphane Jauréguiberry; Pierre Tattevin; Arnaud Tarantola; François Legay; Adama Tall; Pierre Nabeth; Hervé Zeller; Christian Michelet
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Elevated Human Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Khashm el Girba, Eastern Sudan.

Authors:  Paul Rahden; Awadalkareem Adam; Angela Mika; Christian Jassoy
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

7.  Seroprevalence of Crimean Congo hemorrhagic fever virus in Ijara District, Kenya.

Authors:  Olivia Wesula Lwande; Zephania Irura; Caroline Tigoi; Edith Chepkorir; Benedict Orindi; Lillian Musila; Marietjie Venter; Anne Fischer; Rosemary Sang
Journal:  Vector Borne Zoonotic Dis       Date:  2012-08-27       Impact factor: 2.133

8.  Crimean congo hemorrhagic fever infection simulating thrombotic thrombocytopenic purpura.

Authors:  Siavash Vaziri; Jafar Navabi; Mandana Afsharian; Babak Sayad; Feizollah Mansouri; Alireza Janbakhsh; Keighobad Ghadiri
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

9.  Co-infection of Malaria and Crimean-Congo Hemorrhagic Fever.

Authors:  B Sharifi-Mood; M Metanat; F Rakhshani; A Shakeri
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

10.  Seroepidemiology of crimean congo hemorrhagic Fever in slaughterhouse workers in north eastern iran.

Authors:  S Chinikar; A Hezareh Moghadam; Sm J Parizadeh; M Moradi; N Bayat; M Zeinali; E Mostafavi
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.